<DOC>
	<DOCNO>NCT02218489</DOCNO>
	<brief_summary>The primary purpose study determine efficacy safety KPI-121 ophthalmic suspension compare vehicle ( placebo ) subject sign symptom inflammatory meibomian gland disease .</brief_summary>
	<brief_title>Safety Efficacy KPI-121 Subjects With Inflammatory Meibomian Gland Disease</brief_title>
	<detailed_description>This Phase II , multicenter , double-masked , randomize , vehicle-controlled , parallel-group study design evaluate efficacy safety KPI-121 ophthalmic suspension versus vehicle subject sign symptom inflammatory meibomian gland disease . The product study 28 day , 1-2 drop instill eye four time daily ( QID ) .</detailed_description>
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>Have document clinical diagnosis inflammatory meibeomian gland disease eye . Known hypersensitivity/contraindication study product ( ) component . Be currently receive treatment glaucoma , history current glaucoma , IOP 21mmHg Visit 1 ( Screening ) Visit 2 ( Randomization ) . Be unwilling discontinue warm compress therapy , lid expression , lid massage 14 day prior Day 1 duration study . Diagnosis : ongoing ocular infection ; severe/serious ocular condition judgment Investigator could confound study assessment limit compliance ; severe/serious systemic disease uncontrolled medical condition judgment Investigator could confound study assessment limit compliance ; expose investigational drug within 30 day prior screen . Have ocular surgery past 90 day require ocular surgery study . In opinion Investigator study coordinator , unwilling unable comply study protocol unable successfully instill eye drop .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Meibomian Gland Disease</keyword>
	<keyword>Blepharitis</keyword>
	<keyword>Eyelid</keyword>
	<keyword>Ocular Discomfort</keyword>
</DOC>